Asari Sadaki, Matsumoto Ippei, Ajiki Tetsuo, Shinzeki Makoto, Goto Tadahiro, Fukumoto Takumi, Ku Yonson
Division of Hepato-Biliary-Pancreatic Surgery, Department of Surgery, Kobe University Graduate School of Medicine, 7-5-2 Kusunoki-cho, Chuo-ku, Kobe, 650-0017, Japan,
Surg Today. 2015 Feb;45(2):181-8. doi: 10.1007/s00595-014-0900-x. Epub 2014 May 6.
We rarely have an opportunity to perform pancreatoduodenectomy (PD) following the onset of severe acute pancreatitis (SAP) for patients with periampullary cancer. The perioperative risks and optimal timing of subsequent PD have, therefore, remained unclear.
Between January 2006 and December 2012, we performed PD in six patients with SAP. We reviewed these six cases, and compared the perioperative risks of morbidity and mortality with those of 81 concurrent PD patients matched for primary cancer without preoperative SAP.
The six patients were classified as having SAP based on the Japanese criteria developed in 2008. The SAP in five patients was caused by ERCP procedures. The median interval from SAP onset to the operation was 111 days. The rate of Grade B/C postoperative pancreatic fistula formation in the SAP patients was significantly higher than that of the 81 control patients (83 vs. 26 %, P < 0.001). In addition, the median postoperative hospital stay was significantly longer in the six SAP patients relative to that of the control patients (40 vs. 30 days, P < 0.001).
An interval of at least 3 months after surgery may be needed to decrease the inflammation of the peripancreas region after SAP. Therefore, unnecessary and low-yield ERCP procedures should be avoided in these patients.
对于壶腹周围癌患者,在发生严重急性胰腺炎(SAP)后,我们很少有机会进行胰十二指肠切除术(PD)。因此,围手术期风险及后续PD的最佳时机仍不明确。
2006年1月至2012年12月期间,我们对6例SAP患者进行了PD。我们回顾了这6例病例,并将其围手术期的发病和死亡风险与81例同期未合并术前SAP的原发性癌症且相匹配的PD患者进行比较。
根据2008年制定的日本标准,这6例患者被归类为患有SAP。5例患者的SAP由内镜逆行胰胆管造影(ERCP)操作引起。从SAP发作到手术的中位间隔时间为111天。SAP患者术后B/C级胰瘘形成率显著高于81例对照患者(83%对26%,P<0.001)。此外,6例SAP患者的术后中位住院时间相对于对照患者显著更长(40天对30天,P<0.001)。
术后可能需要至少3个月的间隔时间来减轻SAP后胰腺周围区域的炎症。因此,应避免在这些患者中进行不必要且收益低的ERCP操作。